1789 (1789) News
Follow 1789 (1789) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 5 public stories across 4 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
ScinoPharm Taiwan Reports NT$5.57M Third-Quarter Net Loss
ScinoPharm Taiwan reported a net loss of NT$5.57 million for the third quarter ended Sept. 30, compared with net profit of NT$15.4 million a year earlier. Revenue was NT$694.089 million versus NT$721.495 million.
EQUITY | Nov 04, 2026, 09:55 AM UTC
M
ScinoPharm Taiwan reports Sep revenue of NT$309.4M
ScinoPharm Taiwan Ltd. reported September revenue of NT$309,439,000 versus NT$177,384,000 in 2025. Jan–Sep revenue was NT$2,032,302,000 versus NT$2,155,381,000 in 2025, according to Taiwan Stock Exchange figures.
EARNINGS | Oct 08, 2026, 09:23 AM UTC
L
AK Medical announces FY2026 dividend payout ratio at least 55%
EQUITY | Sep 10, 2026, 01:36 AM UTC
M
AK Medical Holdings reports H1 net income attributable to shareholders
AK Medical Holdings logged H1 net income attributable of RMB 196.7 million, according to TradingView News.
EQUITY | Aug 26, 2026, 03:47 PM UTC
L
China's AK Medical interim profit rises on overseas, digital sales
China's AK Medical interim profit rises on overseas, digital sales
GEOPOLITICS | Aug 26, 2026, 12:29 PM UTC